z-logo
Premium
Synthese von Humaninsulin. II. Aufbau des cyclischen Fragments A(1–13)
Author(s) -
Sieber Peter,
Kamber Bruno,
Eisler Karel,
Hartmann Albert,
Riniker Bernhard,
Rittel Werner
Publication year - 1976
Publication title -
helvetica chimica acta
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.74
H-Index - 82
eISSN - 1522-2675
pISSN - 0018-019X
DOI - 10.1002/hlca.19760590510
Subject(s) - chemistry , stereochemistry , disulfide bond , cysteine , human insulin , residue (chemistry) , azide , derivative (finance) , insulin , biochemistry , organic chemistry , enzyme , medicine , financial economics , economics , endocrinology
Synthesis of human insulin. II. Preparation of the A(1–13) fragment. The present report gives a detailed account of the synthesis of the protected tridecapeptide A(1–13), BocGlyIleValGlu(OBu t )Gln Ser(Bu t )LeuOH ( 20 ), an essential intermediate in the recently published total synthesis of human insulin [1]. The main feature in the synthesis of 20 was the specific formation of a disulfide bond between A6 and A11 in the presence of an additional cysteine residue (A7). The selective ring closure was accomplished with the segment A(6–13), HCys(Trt)Cys(Acm)Thr(Bu t )Ser(Bu t )IleCys(Trt)Ser(Bu t )LeuOH ( 18 ), which was obtained by way of conventional synthesis routes. Treatment of 18 with iodine in trifluoroethanol formed the desired disulfide bridge from the two S ‐trityl‐cysteine residues without affecting the S ‐acetamidomethyl‐protected cysteine A7. A final azide coupling with the N ‐terminal derivative A(1–5) ( 3 ) provided the tridecapeptide fragment 20 as a crystalline compound.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom